X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
oncology (60) 60
humans (48) 48
female (39) 39
male (34) 34
cancer (32) 32
middle aged (30) 30
mutation (30) 30
aged (28) 28
adult (24) 24
therapy (20) 20
acquired-resistance (19) 19
aged, 80 and over (18) 18
deoxyribonucleic acid--dna (18) 18
mutations (18) 18
patients (18) 18
circulating tumor dna (17) 17
heterogeneity (17) 17
tumors (17) 17
cell-free dna (16) 16
open-label (16) 16
high-throughput nucleotide sequencing (14) 14
liquid biopsy (14) 14
biomarkers, tumor - genetics (13) 13
egfr (13) 13
lung cancer (13) 13
lung-cancer (13) 13
circulating tumor dna - genetics (11) 11
lung neoplasms - genetics (11) 11
retrospective studies (11) 11
amplification (10) 10
article (10) 10
biomarkers, tumor - blood (10) 10
biopsy (10) 10
crizotinib (10) 10
genetic aspects (10) 10
genomics (10) 10
metastasis (10) 10
targeted therapy (10) 10
carcinoma (9) 9
chemotherapy (9) 9
gene sequencing (9) 9
next-generation sequencing (9) 9
prognosis (9) 9
young adult (9) 9
abridged index medicus (8) 8
alterations (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
circulating tumor dna - blood (8) 8
ctdna (8) 8
diagnosis (8) 8
dna sequencing (8) 8
genes (8) 8
nsclc (8) 8
prospective studies (8) 8
adenocarcinoma (7) 7
breast cancer (7) 7
breast-cancer (7) 7
care and treatment (7) 7
clinical trials (7) 7
dna, neoplasm - genetics (7) 7
drug resistance, neoplasm - genetics (7) 7
endocrinology & metabolism (7) 7
epidermal growth factor receptors (7) 7
erbb receptors - genetics (7) 7
experimental design (7) 7
follow-up studies (7) 7
gene amplification (7) 7
genomics - methods (7) 7
inhibitors (7) 7
kinases (7) 7
metastases (7) 7
resistance (7) 7
thyroid nodule - pathology (7) 7
trastuzumab (7) 7
animals (6) 6
biopsy, fine-needle (6) 6
cell biology (6) 6
combination (6) 6
liquid biopsies (6) 6
management (6) 6
medicine (6) 6
neoplasm metastasis (6) 6
neoplasm staging (6) 6
neoplasms - genetics (6) 6
p53 protein (6) 6
receptor, erbb-2 - genetics (6) 6
solid tumors (6) 6
treatment outcome (6) 6
1st-line treatment (5) 5
activation (5) 5
adenocarcinoma - genetics (5) 5
adolescent (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
azd9291 (5) 5
biomarkers (5) 5
blood (5) 5
cell line, tumor (5) 5
cell lung-cancer (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 02/2018, Volume 8, Issue 2, pp. 164 - 173
"Liquid biopsy" approaches analyzing cell-free DNA (cfDNA) from the blood of patients with cancer are increasingly utilized in clinical practice. However, it... 
TARGETED THERAPY | KRAS MUTATIONS | HETEROGENEITY | EGFR MONOCLONAL-ANTIBODIES | EVOLUTION | ONCOLOGY | CLONAL HEMATOPOIESIS | ACQUIRED-RESISTANCE | EXTRACELLULAR DOMAIN | BLOCKADE | CETUXIMAB RESISTANCE | Cell-free DNA | colorectal cancer | circulating tumor DNA
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140712
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 8, pp. 705 - 715
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2017, Volume 49, Issue 12, pp. 1693 - 1704
Journal Article
Cancer Discovery, ISSN 2159-8274, 09/2018, Volume 8, Issue 9, pp. 1096 - 1111
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 01/2020, Volume 26, Issue 2, pp. 439 - 449
Purpose: Although patients with advanced-stage non-small cell lung cancers (NSCLC) harboring MET exon 14 skipping mutations (METex14) often benefit from MET... 
IMPACT | ACTIVATION | MODELS | ONCOLOGY | TYROSINE KINASE | ADENOCARCINOMAS | ACQUIRED-RESISTANCE | CRIZOTINIB | ANTITUMOR-ACTIVITY | INSIGHT | CONFERS RESISTANCE
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5101 - 5111
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2013, Volume 154, Issue 6, pp. 1420 - 1427
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2018, Volume 24, Issue 12, pp. 2732 - 2739
Purpose: Small cell carcinoma of the prostate (SCCP) is an aggressive disease that can arise de novo or by transdifferentiation from prostate adenocarcino ma.... 
ALK | CONSORTIUM | LUNG-CANCER | ONCOLOGY | SAFETY | DISEASE | BIOLOGY | CRIZOTINIB | TARGETS | NEUROBLASTOMA | CHEMOTHERAPY | Immunohistochemistry | Liquid Biopsy | Carcinoma, Small Cell - genetics | Humans | Carbazoles - administration & dosage | Male | Gene Expression Profiling | Carcinoma, Small Cell - mortality | Prostatic Neoplasms - diagnosis | Protein Kinase Inhibitors - adverse effects | Biomarkers, Tumor | Anaplastic Lymphoma Kinase - genetics | Neoplasm Metastasis | Neoplasm Grading | Prostatic Neoplasms - genetics | Adult | Female | Prostatic Neoplasms - drug therapy | Carbazoles - adverse effects | Piperidines - administration & dosage | Carcinoma, Small Cell - drug therapy | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Small Cell - diagnosis | Prostatic Neoplasms - mortality | Positron Emission Tomography Computed Tomography | Protein Kinase Inhibitors - administration & dosage | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Cell Line, Tumor | Carbazoles - therapeutic use | High-Throughput Nucleotide Sequencing | Mutation | Neoplasm Staging | Adenocarcinoma | Cell culture | Pathogenesis | Lung cancer | ALK protein | Medical services | mRNA | Neuroblastoma | Kinases | Gene sequencing | Alterations | Organoids | Protein-tyrosine kinase | Phosphopyruvate hydratase | Deoxyribonucleic acid--DNA | Lymphoma | Patients | Molecular chains | Inhibitors | Experimental design | Lymphomas | Prostate cancer | Prostate | DNA sequencing | Cancer | Tumors | Small cell carcinoma | Neuroendocrine prostate cancer | ALK F1174
Journal Article
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 05/2019, Volume 25, Issue 10, pp. 3046 - 3053
Purpose: ERBB2 (HER2) amplification is an emerging biomarker in colon cancer, conferring sensitivity to combination anti-HER2 therapy. Measurement of HER2 copy... 
COLON-CANCER | HETEROGENEITY | LAPATINIB | AMPLIFICATION | CIRCULATING TUMOR DNA | ONCOLOGY | BLOCKADE | EXPRESSION
Journal Article